The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
Clinical trial NCT06220552 · RECRUITING
Trial details
- NCT number
- NCT06220552
- Sponsor
- Fifth Affiliated Hospital, Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2027-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.